Photodamage Effectively Treated With Quasi-Ablative Approach - Skin and Allergy News Digital Network
Photodamage Effectively Treated With Quasi-Ablative Approach Skin and Allergy News Digital Network The nonablative 1540-nm fractional laser can be safely converted to a quasi-ablative device for treating facial actinic keratoses and photodamage, according to Dr. Moshe Lapidoth. By slightly modifying technique, a 50%-75% improvement in actinic ...
Glaxo's Melanoma Cocktail Slows Cancer in Study - Bloomberg
Skin conditions: What is seborrheic keratosis? Newsolio (blog) Seborrheic keratoses are growths on the skin that appear in adulthood and tend to increase in size and number as an individual ages. They are not skin cancer, and are no more likely to become malignant than is normal skin. Keratin is the material that ...
DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies of Levulan(R ... - MarketWatch (press release)
DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies of Levulan(R ... MarketWatch (press release) ... announced today that patient enrollment is complete in its Phase 2 clinical trial studying the broad area application with 1, 2 and 3-hour (short) drug incubation for the treatment of actinic keratoses (AKs) of the face or scalp.
Protecting our largest organ Irish Medical Times Long exposure to mild sunshine causes ageing of the skin, solar keratoses and the development of the aforesaid tumours and the consistent use of sunscreens will help to prevent these. In malignant melanoma, the picture is less clear; it certainly does ...
DUSA Pharmaceuticals Reports First Quarter 2012 Corporate Highlights and ... - MarketWatch (press release)
DUSA Pharmaceuticals Reports First Quarter 2012 Corporate Highlights and ... MarketWatch (press release) ... it had completed patient enrollment in its Phase 2 clinical trial studying the broad area application with 1, 2 and 3-hour (short) drug incubation using the Levulan(R) Kerastick(R) for the treatment of actinic keratoses (AKs) of the face or scalp.
DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies of Levulan(R ... - PipelineReview.com (press release)
DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies of Levulan(R ... PipelineReview.com (press release) ... announced today that patient enrollment is complete in its Phase 2 clinical trial studying the broad area application with 1, 2 and 3-hour (short) drug incubation for the treatment of actinic keratoses (AKs) of the face or scalp.
EXPOSURE TO SUN CAN BE DANGEROUS FOR PETS - U-T San Diego
EXPOSURE TO SUN CAN BE DANGEROUS FOR PETS U-T San Diego Dogs and cats can get precancerous lesions called actinic keratoses, which can then progress to skin cancers such as squamous cell or basal cell carcinoma. Some dogs can develop tumors of the blood vessels called hemangiomas.
DUSA Pharmaceuticals, Inc.(R) to Host First Quarter 2012 Corporate Highlights ... - MarketWatch (press release)
DUSA Pharmaceuticals, Inc.(R) to Host First Quarter 2012 Corporate Highlights ... MarketWatch (press release) ... acid HCl) for Topical Solution, 20% plus blue light illumination using DUSA's BLU-U(R) Blue Light Photodynamic Therapy Illuminator is currently approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp.
Time on your hands Brisbane Times (blog) "Variations in colour include brown spots, such as seborrhoeic or actinic keratoses, also known as sun or liver spots. Prominent veins and tendons often lead to a 'claw hand' appearance due to the loss of dermal and subcutaneous volume," Dr Austin said ...
What our clients and candidates are saying about us: You do an excellent job in prepping your candidates. Much better then any other recruiter, that I have worked with. - Susanne
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.